Influence of insulin-like growth factor-1 and hepatocyte growth factor on carotid atherosclerosis and cognitive function in the elderly

Dementia and Geriatric Cognitive Disorders

Volumn 18, Issue 1, 2004, Pages 67-74

  Watanabe, Takuya ^a   Yamamoto, Hideki ^a   Idei, Tsunenori ^a   Iguchi, Takashi ^a   Katagiri, Takashi ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

Cognitive function; Elderly; Hepatocyte growth factor; Insulin like growth factor 1; Intima media thickness

Indexed keywords

LIPID PEROXIDE; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SCATTER FACTOR; SOMATOMEDIN C;

AGED; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY; CAROTID ARTERY DISEASE; CHOLESTEROL BLOOD LEVEL; COGNITION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; INTIMA; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE; TUNICA MEDIA;

AGED; AGED, 80 AND OVER; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CHOLESTEROL, LDL; COGNITION; DEMENTIA, VASCULAR; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LIPIDS; LIPOPROTEIN(A); MALE; NEUROPSYCHOLOGICAL TESTS; SENILE PLAQUES;

EID: 3042554200     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000077812     Document Type: Article

References (56)

1. Forette F, Seux ML, Staessen JA, Thijs L, Birkenhager WH, Babarskiene MR, Babeanu S, Bossini A, Gil-Extremera B, Girerd X, Laks T, Lilov E, Moisseyev V, Tuomilehto J, Vanhanen H, Webster J, Yodfat Y, Fagard R: Prevention of dementia in randomised doubleblind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998;352:1347-1351.
2. Jick H, Zornberg GL, Jick SS, Seshadri S, Drachman DA: Statins and the risk of dementia. Lancet 2000;356:1627-1631.
3. Giubilei F, D'Antona R, Antonini R, Lenzi GL, Ricci G, Fieschi C: Serum lipoprotein pattern variations in dementia and ischemic stroke. Acta Neurol Scand 1990;81:84-86.
4. McIlroy SP, Dynan KB, Lawson JT, Patterson CC, Passmore AP: Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer Disease in Northern Ireland. Stroke 2002;33:2351-2356.
5. Bianchi M, Sacerdote P, Panerai AE: Cytokines and cognitive function in mice. Biol Signals Recept 1998;7:45-54.
6. Bruunsgaard H, Andersen-Ranberg K, Jeune B, Pedersen AN, Skinhoj P, Pedersen BK: A high plasma concentration of TNF-alpha is associated with dementia in centenarians. J Gerontol A Biol Sci Med Sci 1999;54:M357-M364.
7. Bayes-Genis A, Conover CA, Schwartz RS: The insulin-like growth factor axis: A review of atherosclerosis and restenosis. Circ Res 2000;86:125-130.
8. Frystyk J, Ledet T, Moller N: Cardiovascular disease and insulin-like growth factor 1. Circulation 2002;106:893-895.
9. Parrizas M, Saltiel AR, LeRoith D: Insulin-like growth factor 1 inhibits apoptosis using the phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways. J Biol Chem 1997;272:154-161.
10. Rollero A, Murialdo G, Fonzi S, Garrone S, Gianelli MV, Gazzerro E, Barreca A, Polleri A: Relationship between cognitive function, growth hormone and insulin-like growth factor 1 plasma levels in aged subjects. Neuropsychobiology 1998;38:73-79.
11. Nakamura Y, Morishita R, Nakamura S, Aoki M, Moriguchi A, Matsumoto K, Nakamura T, Higaki J, Ogihara T: A novel vascular modulator, hepatocyte growth factor, is associated with systolic pressure. Hypertension 1996;28:409-413.
12. Yoshitomi Y, Kojima S, Umemoto T, Kubo K, Matsumoto Y, Yano M, Sugi T, Kuramochi M: Serum hepatocyte growth factor in patients with peripheral arterial occlusive disease. J Clin Endocrinol Metab 1999;84:2425-2428.
13. Yamamoto Y, Kohara K, Tabara Y, Igase M, Nakura J, Miki T: Plasma hepatocyte growth factor and the relationship between risk factors and carotid atherosclerosis. Hypertens Res 2002;25:661-667.
14. Sato T, Yoshinouchi T, Sakamoto T, Fujieda H, Murao S, Sato H, Kobayashi H, Ohe T: Hepatocyte growth factor (HGF): A new biochemical marker for acute myocardial infarction. Heart Vessels 1997;12:241-246.
15. Nakamura Y, Morishita R, Higaki J, Kida I, Aoki M, Moriguchi A, Yamada K, Hayashi S, Yo Y, Nakano H, Matsumoto K, Nakamura T, Ogihara T: Hepatocyte growth factor is a novel member of the endothelium-specific growth factors: Additive stimulatory effect of hepatocyte growth factor with basic fibroblast growth factor but not with vascular endothelial growth factor. J Hypertens 1996;14:1067-1072.
16. Hayashi S, Morishita R, Nakamura S, Yamamoto K, Moriguchi A, Nagano T, Taiji, Noguchi H, Matsumoto K, Nakamura T, Higaki J, Ogihara T: Potential role of hepatocyte growth factor, a novel angiogenic growth factor, in peripheral arterial disease. Circulation 1999; 100(suppl):II301-II308.
17. Miyazawa T, Matsumoto K, Ohmichi H, Katoh H, Yamashima T, Nakamura T: Protection of hippocampal neurons from ischemia-induced delayed neuronal death by hepatocyte growth factor: A novel neurotrophic factor. J Cereb Blood Flow Metab 1998;18:345-348.
18. Zhang L, Himi T, Morita I, Murota S: Hepatocyte growth factor protects cultured rat cerebellar granule neurons from apoptosis via the phosphatidylinositol-3 kinase/Akt pathway. J Neurosci Res 2000;59:489-496.
19. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Scheinberg P: Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-260.
20. Folstein MF, Folstein SE, McHugh PR: 'Mini-Mental State': A practical method for grading the cognitive state of patients for the clinician. J Phychiatr Res 1975;12:189-198.
21. Mori E, Mitani Y, Yanadori A: Usefulness of a Japanese version of the Mini-Mental State Test in neurological patients. Jpn J Neuropsychol 1985;1:82-89 (in Japanese).
22. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
23. Watanabe T, Koba S, Kawamura M, Itokawa, M, Idei T, Nakagawa Y, Iguchi T, Katagiri T: Small dense low-density lipoprotein and carotid atherosclerosis in relation to vascular dementia. Metabolism 2004;53:476-482.
24. Watanabe T, Itokawa M, Nakagawa Y, Iguchi T, Katagiri T: Increased levels of insulin-like growth factor binding protein-3 in hypertensive patients with carotid atherosclerosis. Am J Hypertens 2003;16:754-760.
25. Nishimura M, Nakano K, Ushiyama M, Nanbu A, Ohtsuka K, Takahashi H, Yoshimura M: Increased serum concentration of human hepatocyte growth factor in proliferative diabetic retinopathy. J Clin Endocrinol Metab 1998;83:195-198.
26. Shiota G, Okano J, Kawasaki H, Kawamoto T, Nakamura T: Serum hepatocyte growth factor levels in liver disease: Clinical implications. Hepatology 1995;21:106-112.
27. Malatino LS, Mallamaci F, Benedetto FA, Bellanuova I, Cataliotti A, Tripepi G, Zoccali C: Hepatocyte growth factor predicts survival and relates to inflammation and intima media thickness in end-stage renal disease. Am J Kidney Dis 2000;36:945-952.
28. Taniguchi T, Tei M, Inada K, Imazawa T, Yamamoto Y, Tominaga T: Serum concentrations of hepatocyte growth factor in breast cancer patients. Clin Cancer Res 1995;1:1031-1034.
29. Takasu S, Tsuchiya M, Mori K, Iwamoto K, Kasahara H, Horikawa H: Development and fundamental studies of non-extract IGF-1/ IGF-II IRMA. Clin Endocrinol (Tokyo) 1996;44:383-391.
30. Tsubouchi H, Niitani Y, Hirono S, Nakayama H, Gohda E, Arakaki N, Sakiyama O, Takahashi K, Kimoto M, Kawakami S, Setoguchi M, Tachikawa T, Shin S, Arima T, Daikuhara Y: Levels of the human hepatocyte growth factor in the serum of patients with various liver diseases determined by an enzyme-linked immunosorbent assay. Hepatology 1991;13:1-5.
31. Yanagihara T: Vascular dementia in Japan. Ann NY Acad Sci 2002;977:24-28.
32. Ceda GP, Dall'Aglio E, Magnacavallo A, Vargas N, Fontana V, Maggio M, Valenti G, Lee PDK, Hintz RL, Hoffman AR: The insulin-like growth factor axis and plasma lipid levels in the elderly. J Clin Endocrinol Metab 1998;83:499-502.
33. Janssen JAMJL, Stolk RP, Pols HAP, Grobbee DE, Lamberts SWJ: Serum total IGF-1, free IGF-1, and IGFBP-1 levels in an elderly population: Relation to cardiovascular risk factors and disease. Arterioscler Thromb Vasc Biol 1998;18:277-282.
34. Aleman A, Verhaar HJ, De Haan EH, De Vries WR, Samson MM, Drent ML, Van der Veen EA, Koppeschaar HP: Insulin-like growth factor-1 and cognitive function in healthy older men. J Clin Endocrinol Metab 1999;84:471-475.
35. Kalmijn S, Janssen JAMLJL, Pols HAP, Lamberts SWJ, Breteler MMB: A prospective study on circulating insulin-like growth factor I (IGF-1), IGF-binding proteins, and cognitive function in the elderly. J Clin Endocrinol Metab 2000;8:4551-4555.
36. Dore S, Kar S, Quition R: Insulin-like growth factor 1 protects and rescues hippocampal neurons against β-amyloid- and human amylininduced toxicity. Proc Natl Acad Sci USA 1997;94:4772-4777.
37. Rotwein P, Burgess SK, Milbrandt JD, Krause JE: Differential expression of insulin-like growth factor genes in rat central nervous system. Proc Natl Acad Sci USA 1988;85:265-269.
38. Guan J, Williams CE, Skinner SJM, Mallard EC, Gluckman PD: The effects of insulin-like growth factor (IGF)-1, IGF-2, and des-IGF-1 on neuronal loss after hypoxic-ischemic brain injury in adult rats: Evidence for a role for IGF binding proteins. Endocrinology 1996;137:893-898.
39. Zheng WH, Kar S, Dore S, Quirion R: Insulinlike growth factor-1 (IGF-1): A neuroprotective trophic factor acting via the Akt kinase pathway. J Neural Transm Suppl 2000;60:261-272.
40. Hong M, Lee VM: Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons. J Biol Chem 1997;272:19547-19553.
41. Paolisso G, Ammendola S, Del Buono A, Gambardella A, Riondino M, Tagliamonte MR, Rizzo MR, Carella C, Varricchio M: Serum levels of insulin-like growth factor-1 (IGF-1) and IGF-1 binding protein-3 in healthy centenarians: Relationship with plasma leptin and lipid concentrations, insulin action and cognitive function. J Clin Endocrinol Metab 1997;82:2204-2209.
42. Van den Beld AW, Bots ML, Janssen JAMLL, Pols HAP, Lamberts SWJ, Grobbee DE: Endogenous hormones and carotid atherosclerosis in elderly men. Am J Epidemiol 2003;157:25-31.
43. Taher TEI, Derksen PWB, de Boer OJ, Spaargaren M, Teeling P, van der Wal AC, Pals ST: Hepatocyte growth factor triggers signaling cascades mediating vascular smooth muscle cell migration. Biochem Biophys Res Commun 2002;1:80-86.
44. Yamamoto Y, Kohara K, Tabara Y, Miki T: Association between carotid arterial remodeling and plasma concentration of circulating hepatocyte growth factor. J Hypertens 2001;19:1975-1979.
45. Morishita R, Moriguchi A, Higaki J, Ogihara T: Hepatocyte growth factor (HGF) as a potential index of severity of hypertension. Hypertens Res 1999;22:161-167.
46. Nishimura M, Ushiyama M, Nanbu A, Ohtsuka K, Takahashi H, Yoshimura M: Serum hepatocyte growth factor as a possible indicator of arteriosclerosis. J Hypertens 1997;15:1137-1142.
47. 1 in cultured hepatic stellate cells. Endocrinology 1997;138:4683-4689.
48. Skrtic S, Wallenius K, Gressner AM, Jansson JO: Insulin-like growth factor signaling pathways in rat hepatic stellate cells: Importance for deoxyribonucleic acid synthesis and hepatocyte growth factor production. Endocrinology 1999;140:5729-5735.
49. Price JA, Kovach SJ, Johnson T, Koniaris LG, Cahill PA, Sitzmann JV, McKillop IH: Insulinlike growth factor 1 is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma. Hepatology 2002;36:1089-1097.
50. Schwab S, Spranger M, Krempien S, Hacke W, Bettendorf: Plasma insulin-like growth factor 1 and IGF binding protein 3 levels in patients with acute cerebral ischemic injury. Stroke 1997;28:1744-1748.
51. Matsumori A, Takano H, Obata JE, Takeda S, Tsuyuguchi N, Ono K, Okada M, Miyamoto T, Ohnishi T, Daikuhara Y, Sasayama S: Circulating hepatocyte growth factor as a diagnostic marker of thrombus formation in patients with cerebral infarction. Circ J 2002;66:216-218.
52. Spallarossa P, Brunelli C, Minuto F, Caruso D, Battistini M, Caponnetto S, Cordera R: Insulin-like growth factor-1 and angiographically documented coronary artery disease. Am J Cardiol 1996;77:200-202.
53. Schuler-Luttmann S, Monnig G, Enbergs A, Schulte H, Breithardt G, Assmann G, Kerber S, von Eckardstein A: Insulin-like growth factorbinding protein-3 is associated with the presence and extent of coronary atherosclerosis. Arterioscler Thromb Vasc Biol 2000;20:1-6.
54. Lai X, Mo F, Jiang G: Observation of clinical effect of acupuncture on vascular dementia and its influence on superoxide dismutase, lipid peroxide and nitric oxide. Zhongguo Zhong Xi Yi Jie He Za Zhi 1998;18:648-651.
55. Muniyappa R, Walsh MF, Rangi JS, Zayas RM, Standley PR, Ram JL, Sowers JR: Insulin like growth factor-1 increases vascular smooth muscle nitric oxide production. Life Sci 1997;61:925-931.
56. Maejima Y, Ueba H, Kuroki M, Yasu T, Hashimoto S, Nabata A, Kobayashi N, Ikeda N, Saito M, Kawakami M: Src family kinases and nitric oxide production are required for hepatocyte growth factor-stimulated endothelial cell growth. Atherosclerosis 2003;167:89-95.